Intellectual Property India Publishes Patent Application for Compositions And Methods Comprising Small Nuclear Rna (snrna) For The Treatment Of Pompe Disease

MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202617093772 A) filed by Regeneron Pharmaceuticals, Inc. on August 03, 2026, for Compositions And Methods Comprising Small Nuclear Rna (snrna) For The Treatment Of Pompe Disease.

Inventors include Bradford, William Henry; Roth, Daniela; Batra, Ranjan; and Leonard, John Patrick.

The application for the patent was published on October 30, 2026, under issue no. 44/2026.

Abstract: SnRNA systems targeting GAA and GYS1 RNA sequences, and polynucleotides and vectors comprising the same, are disclosed herein. Further disclosed are methods of treating Pompe disease, e.g., using such RNA sequences, polynucleotides and vectors.

Disclaimer: Curated by HT Syndic...